KAYNE RICHARD A enters EIGER BIOPHARMACEUTICALS, INC. with 5.10M shares across direct and indirect positions
This filing by KAYNE RICHARD A establishes the baseline for all future Form 4 insider transaction reports at EIGER BIOPHARMACEUTICALS, INC..
Indirect
Filed: 10/30/2023ACC: 0001140361-23-050238
10% Owner
Since Oct 2023
5.10M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
3
Security positions
5.10M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned2.70M
Common Stock
IndirectShares owned1.67M
Common Stock
IndirectShares owned729.89K
Total
5.10M indirect5.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.70M | Indirect |
| Common Stock | 1.67M | Indirect |
| Common Stock | 729.89K | Indirect |
| Total | 5.10M | 5.10M indirect |
Derivative Holdings0
No derivative holdings reported